96. J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD,Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J,Marcom PK, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, ReedEC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, SomloG, Telli ML, Ward JH, Kumar R, Shead DA.Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group ofneoplastic lesions in the breast ducts. The goal for management of DCIS is toprevent the development of invasive breast cancer. This manuscript focuses on theNCCN Guidelines Panel recommendations for the workup, primary treatment, riskreduction strategies, and surveillance specific to DCIS.Copyright Â© 2018 by the National Comprehensive Cancer Network.DOI: 10.6004/jnccn.2018.0012 PMID: 29523670 